Citation Impact
Citing Papers
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
2010 Standout
The Human SepSecS-tRNA Sec Complex Reveals the Mechanism of Selenocysteine Formation
2009 StandoutScienceNobel
Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials.
1990
Thiazolidinediones
2004 Standout
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
1992 Standout
Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
2010
The argument for increasing selenium intake
2002
Inflammation and metabolic disorders
2006 StandoutNature
Selenium in cancer prevention: a review of the evidence and mechanism of action
2005
Effects of Torcetrapib in Patients at High Risk for Coronary Events
2007 Standout
Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
1990 Standout
By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?
1994
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
1995 Standout
The metabolic syndrome
2010 Standout
High-Density Lipoprotein as a Therapeutic Target
2007
Should there be a moratorium on the use of cholesterol lowering drugs?
1992
Beyond Cholesterol
1989 Standout
The Value of Lowering Cholesterol after Myocardial Infarction
1990
The Helsinki Heart Study: an 8.5‐year safety and mortality follow‐up
1994
Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors
1992 StandoutNature
Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris
1995 Standout
Selenium and human health
2012 Standout
Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: Conceptual issues and research evidence.
2003 Standout
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
1990 StandoutNature
Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy Men
1995 Standout
Sick individuals and sick populations
2001 Standout
Antioxidants and Atherosclerotic Heart Disease
1997 Standout
The importance of selenium to human health
2000 Standout
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
Might treatment of hypercholesterolaemia increase non-cardiac mortality?
1991
Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: The cholesterol and recurrent events trial (CARE)
1991
Food-chain selenium and human health: emphasis on intake
2008
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
1994 Standout
Cholesterol Reduction in Cardiovascular Disease — Clinical Benefits and Possible Mechanisms
1995
Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000
2007 Standout
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
1996 Standout
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
Atherosclerosis — An Inflammatory Disease
1999 Standout
Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease
1993
Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
1999 Standout
Plasma fibrinogen levels and their correlates in 6457 coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) study
1995
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Insulin resistance and atherosclerosis
2006
Effects of statins on stroke prevention in patients with and without coronary heart disease: A meta-analysis of randomized controlled trials
2004
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
1997 Standout
Reduction of Mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by Combined Treatment with Clofibrate and Nicotinic Acid
1988
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
2011 Standout
C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women
2000 Standout
Hypertriglyceridemia, Atherogenic Dyslipidemia, and the Metabolic Syndrome
1998
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
2004 Standout
Atherosclerosis
2001 Standout
Bias in meta-analysis detected by a simple, graphical test
1997 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
1987 Standout
Recent advances in diabetic retinopathy
1981
Prediction of Coronary Heart Disease Using Risk Factor Categories
1998 Standout
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
2004 Standout
Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.
1984
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
1998 Standout
Total Synthesis of α-Pyrone Meroterpenoids, Novel Bioactive Microbial Metabolites
2005 StandoutNobel
Regulation of Plasma Cholesterol by Lipoprotein Receptors
1981 StandoutScienceNobel
Carcinogenesis by Hepatic Peroxisome Proliferators: Evaluation of the Risk of Hypolipidemic Drugs and Industrial Plasticizers to Humans
1983
Lipid Alterations and Decline in the Incidence of Coronary Heart Disease in the Helsinki Heart Study
1988
Is There a Role for Fibrates in the Management of Dyslipidemia in the Metabolic Syndrome?
2007
Effect of gemfibrozil on biliary lipid metabolism in normolipemic subjects
1985
Strategy of prevention: lessons from cardiovascular disease.
1981
Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)
1994
Discussion
1999
The Metabolic Syndrome
2008 Standout
Myopathy and Rhabdomyolysis Associated With Lovastatin-Gemfibrozil Combination Therapy
1990
Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men.
1994
Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes
2003 Standout
Cholesterol Reduction Yields Clinical Benefit
1998
Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome.
1992
Epidemiology as a Guide to Clinical Decisions
1980
DIETARY FATS AND CORONARY HEART DISEASE: UNFINISHED BUSINESS
1979
Properties of hypolipidemic peroxisome proliferators in the lymphocyte [3H]thymidine and Salmonella mutagenesis assays.
1980
Gemfibrozil in the Treatment of Dyslipidaemia A 5‐year follow‐up study
1982
Characterization of Mammalian Selenoproteomes
2003 StandoutScience
The Inverse Relation between Fish Consumption and 20-Year Mortality from Coronary Heart Disease
1985 Standout
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Cholesterol Reduction Yields Clinical Benefit
1995
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
1988 Standout
Works of Jane Cooper being referenced
A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.
1978
Selenium and Immunocompetence in Patients with Head and Neck Cancer
2000
Antithrombin III and arterial disease
1991
Fibrinogen level as a predictor of mortality in survivors of myocardial infarction
1991
CLOFIBRATE AND GALLSTONES
1975
Strenuous exercise, plasma fibrinogen, and factor VII activity.
1992